Evaluation of JAK2V617F in B and T Cell Neoplasms: Identification of JAK2V617F Mutation of Undetermined Significance (JMUS) in the Bone Marrow of Three Individuals

Publisher： Karger

E-ISSN： 1421-9662|118|4|209-214

ISSN： 0001-5792

Source： Acta Haematologica, Vol.118, Iss.4, 2007-11, pp. : 209-214

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukocytosis, JAK2V617F Mutation, and Hemostasis in Myeloproliferative Disorders

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 36, Iss. 3-4, 2009-01 ,pp. : 148-159

Karger

Access to resources Recommend Favorite

Is the JAK2 V617F Mutation a Hallmark for Different Forms of Thrombosis?

By  

Acta Haematologica, Vol. 124, Iss. 1, 2010-07 ,pp. : 49-56

Karger

Access to resources Recommend Favorite

No Evidence for JAK2V617F Mutation in Monoclonal B Cells in 2 Patients with Polycythaemia Vera and Concurrent Monoclonal B Cell Disorder

By  

Acta Haematologica, Vol. 128, Iss. 3, 2012-08 ,pp. : 183-186

Karger

Access to resources Recommend Favorite

Proteolytic Matrix Metallopeptidases and Inhibitors in BCR-ABL1-Negative Myeloproliferative Neoplasms: Correlation with JAK2V617F Mutation Status

By  

Acta Haematologica, Vol. 126, Iss. 1, 2011-04 ,pp. : 54-62

Karger

Access to resources Recommend Favorite

KITD816V and JAK2V617F mutations are seen recurrently in hypereosinophilia of unknown significance

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 774-777

John Wiley & Sons Inc

Access to resources Recommend Favorite